Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis

  • Authors:
    • Min Chen
    • Jian Wu
    • Xing‑Xing Zhang
    • Qiong Wang
    • Shi‑Hai Yan
    • Hai‑Dan Wang
    • Sheng‑Lin Liu
    • Xi Zou
  • View Affiliations

  • Published online on: November 21, 2016     https://doi.org/10.3892/ol.2016.5404
  • Pages: 370-376
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Sesquiterpenoids are a major type of compound found in Solanum lyratum (S. lyratum). The present study aimed to investigate whether sesquiterpenoids from S. lyratum demonstrated cytotoxicity against the MCF-7, HCT-8, A-549, SGC-7901 and BEL-7402 cell lines, and the mechanism of solajiangxin H and lyratol D, which exhibited high cytotoxicity against SGC-7901 cells (half maximal inhibitory concentration, IC50=4.8 and 5.9 µg/ml), was associated with mitochondria-mediated apoptosis. The results of the Cell Counting Kit-8 assay indicated that 15 sesquiterpenoids had cytotoxicity against the aforementioned cultured cells. The results of DAPI staining and western blot analysis, used to study the anticancer mechanisms of solajiangxin H and lyratol D in SGC-7901 cells, suggested that solajiangxin H and lyratol D induced the apoptosis of SGC-7901 cells significantly (P<0.01), downregulated the expression of the antiapoptotic proteins B‑cell lymphoma (Bcl)-2 and survivin, and upregulated the expression of the proapoptotic proteins Bcl-2-like protein 4, second mitochondria-derived activator of caspase, cleaved (c)-caspase-3 and c-caspase-9. The present study therefore demonstrated that 15 sesquiterpenoids from S. lyratum exhibited anticancer activity in MCF-7, HCT-8, A-549, SGC-7901 and BEL-7402 cells, and that the anticancer mechanisms of solajiangxin H and lyratol D may be associated with mitochondria-mediated apoptosis. Additionally, the present study provides evidence in support of the hypothesis that S. lyratum may be a promising candidate for the development of novel cancer therapies.
View Figures
View References

Related Articles

Journal Cover

January-2017
Volume 13 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen M, Wu J, Zhang XX, Wang Q, Yan SH, Wang HD, Liu SL and Zou X: Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis. Oncol Lett 13: 370-376, 2017
APA
Chen, M., Wu, J., Zhang, X., Wang, Q., Yan, S., Wang, H. ... Zou, X. (2017). Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis. Oncology Letters, 13, 370-376. https://doi.org/10.3892/ol.2016.5404
MLA
Chen, M., Wu, J., Zhang, X., Wang, Q., Yan, S., Wang, H., Liu, S., Zou, X."Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis". Oncology Letters 13.1 (2017): 370-376.
Chicago
Chen, M., Wu, J., Zhang, X., Wang, Q., Yan, S., Wang, H., Liu, S., Zou, X."Anticancer activity of sesquiterpenoids extracted from Solanum lyratum via the induction of mitochondria-mediated apoptosis". Oncology Letters 13, no. 1 (2017): 370-376. https://doi.org/10.3892/ol.2016.5404